| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36c11706ea3d36aada1f27d31cd86246 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4abed865550787a1ff0f2459b2bcd4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c88c8782fe2893da85acdec6bf98ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffbf83cbfd3ae2e8800b0675f51efcb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7950eb0ccd2e5f410605ba99fe741cf0 |
| publicationDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2732280-T3 |
| titleOfInvention |
Pharmaceutical product of calcium aluminosilicate |
| abstract |
An oral composition for use as a supportive therapy for treating diarrhea in a subject comprising: an effective amount of an isolated low-sodium anti-diarrheal calcium aluminosilicate ("CASAD"), in which the low-sodium isolated CASAD has a average particle size between 5 and 100 micrometers, is substantially free of contamination with toxic dioxins and heavy metals and has a chemical composition comprising CaO above about 3.2%; MgO ranging from 4.0 to 5.4%; Fe2O3 ranging from 5.4 to 6.5%; K2O ranging from 0.50 to 0.90%; Na2O ranging from 0.10 to 0.30%; MnO ranging from 0.01 to 0.03%; Al2O3 ranging from 14.8 to 18.2%; and SiO2 ranging from 62.4 to 73.5%; in which, the chemical composition is given as a percentage by weight. |
| priorityDate |
2006-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |